BioCentury
ARTICLE | Clinical News

Probuphine buprenorphine: Completed Phase III enrollment

December 8, 2014 8:00 AM UTC

Titan said partner Braeburn Pharmaceuticals S.p.r.l. (Princeton, N.J.) completed enrollment of 178 clinically stable patients in a double-blind, placebo-controlled Phase III trial evaluating 4 Probup...